Minimal impact of IL-17 and IL-12/23 inhibition on SARS-CoV-2/COVID-19 antibody response in psoriasis patients

Leore Lavin, Benjamin Ungar, Brianna Sa, Emma Guttman-Yassky

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number5
JournalArchives of Dermatological Research
Volume316
Issue number1
DOIs
StatePublished - Jan 2024

Keywords

  • Antibodies
  • COVID-19
  • IL-12/23 inhibitors
  • IL-17 inhibitors
  • Immune response
  • Psoriasis
  • SARS-CoV-2

Cite this